USE OF BIOLOGICAL DMARDS, BUT NOT OF CONVENTIONAL SYNTHETIC DMARDS OR STEROIDS, MAY BE RELEVANT TO INCREASED ENERGY INTAKE IN PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0
|
作者：
Masuko, K. [1 ,2 ]
Mizukami, Y. [3 ]
Tohma, S. [4 ]
Matsui, T. [5 ]
机构：
[1] Int Univ Hlth & Welf, Clin Res Ctr Med, Tokyo, Japan
[2] Sanno Med Ctr, Hlth Evaluat & Promot Ctr, Tokyo, Japan
[3] Sagami Womens Univ, Grad Sch Nutr Sci, Sagamihara, Kanagawa, Japan
[4] Natl Hosp Org, Sagamihara Natl Hosp, Clin Res Ctr Allergy & Rheumatol, Sagamihara, Kanagawa, Japan
[5] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Tokyo, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.4603
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0333
引用
收藏
页码：1165 / 1165
页数：1
相关论文
共 50 条
  • [41] EFFECTS OF BIOLOGICAL-DMARDS ON THE SERUM URIC ACID LEVEL IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Miwa, Y.
    Miwa, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1347 - 1347
  • [42] SWITCHING RATE OF BIOLOGICAL DMARDS IN RHEUMATOID ARTHRITIS PATIENTS: TREASURE REAL LIFE DATA
    Kalyoncu, Umut
    Ertenli, Ali Ihsan
    Erden, Abdulsamet
    Kucuksahin, Orhan
    Kasifoglu, Timucin
    Dalkilic, Ediz
    Bes, Cemal
    Kanitez, Nilufer Alpay
    Emmungil, Hakan
    Atagunduz, Pamir
    Coskun, Belkis Nihan
    Yagiz, Burcu
    Koca, Suleyman Serdar
    Cinar, Muhammet
    Ates, Askin
    Akar, Servet
    Gercik, Onay
    Ersozlu, Duygu
    Yazisiz, Veli
    Kimyon, Gezmis
    Aydin, Muge
    Mercan, Ridvan
    Oz, Burak
    Bilge, Nazife Sule Yasar
    Akar, Zeynel Abidin
    Karadag, Omer
    Dincer, Ayse Bahar Kelesoglu
    Yilmaz, Sedat
    Ilgen, Ufuk
    Pehlivan, Yavuz
    Terzioglu, Ender
    Kilic, Levent
    Erten, Sukran
    Kiraz, Sedat
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 713 - 714
  • [43] IMPACT OF MAINTENANCE THERAPY WITH LOW-DOSE GLUCOCORTICOIDS IN PATIENTS UNDERGOING BIOLOGICAL AND TARGETED SYNTHETIC DMARDS FOR RHEUMATOID ARTHRITIS
    Giollo, A.
    Zen, M.
    Salvato, M.
    Frizzera, F.
    Botsios, K.
    Ramonda, R.
    Doria, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 487 - 488
  • [44] Do the drug doses of conventional synthetic DMARDs used for the treatment of biologic/targeted-synthetic DMARDs naive rheumatoid arthritis patients affect QuantiFERON-TB Gold Plus test results?
    Zehra Ozsoy
    Adem Ozdemir
    Mustafa Ekici
    Emre Bilgin
    Levent Kılıc
    Sedat Kiraz
    Zeynep Sarıbas
    Burçin Sener
    Omer Karadag
    Rheumatology International, 2023, 43 : 1445 - 1451
  • [45] Do the drug doses of conventional synthetic DMARDs used for the treatment of biologic/targeted-synthetic DMARDs naive rheumatoid arthritis patients affect QuantiFERON-TB Gold Plus test results?
    Ozsoy, Zehra
    Ozdemir, Adem
    Ekici, Mustafa
    Bilgin, Emre
    Kilic, Levent
    Kiraz, Sedat
    Saribas, Zeynep
    Sener, Burcin
    Karadag, Omer
    RHEUMATOLOGY INTERNATIONAL, 2023, 43 (08) : 1445 - 1451
  • [46] Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs
    Strangfeld, A.
    Richter, A.
    Siegmund, B.
    Herzer, P.
    Rockwitz, K.
    Demary, W.
    Aringer, M.
    Meissner, Y.
    Zink, A.
    Listing, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (03) : 504 - 510
  • [47] PERIODONTAL DISEASE IN RHEUMATOID ARTHRITIS: RESULTS FROM A COHORT AT TREATMENT WITH BIOLOGICAL, CLASSICAL AND TARGETED SYNTHETIC DMARDS
    Dos-Santos, R.
    Otero, F.
    Perez-Pampin, E.
    Mera Varela, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 524 - 524
  • [48] TREATMENT WITH BIOLOGICAL AND NON-BIOLOGICAL DMARDS IS A MODIFIER CONDITION OF PERIODONTAL DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Giraldo, S.
    Romero-Sanchez, C.
    Rodriguez, C.
    Moreno, P. Santos
    Mesa, A. M.
    Lafaurie, G. I.
    De Avila, J.
    Castillo, D. M.
    Chalem, P.
    Bello-Gualtero, J. M.
    Valle-Onate, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 491 - 491
  • [49] Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort
    Cédric Lukas
    Julia Mary
    Michel Debandt
    Claire Daïen
    Jacques Morel
    Alain Cantagrel
    Bruno Fautrel
    Bernard Combe
    Arthritis Research & Therapy, 21
  • [50] Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort
    Lukas, Cedric
    Mary, Julia
    Debandt, Michel
    Daien, Claire
    Morel, Jacques
    Cantagrel, Alain
    Fautrel, Bruno
    Combe, Bernard
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (01)
12345